Doug W. Hobbs

Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists

Zhenfu Han, Jerome S. Pinkner, Bradley Ford et al. · Journal of Medicinal Chemistry · 2010 · 231 citations

Orally active, nonpeptide oxytocin antagonists

B. Evans, James L. Leighton, Kenneth E. Rittle et al. · Journal of Medicinal Chemistry · 1992 · 80 citations · Full text

Medicinal Chemistry, Anesthesia, Medicine +15

Development of Orally Active Oxytocin Antagonists:  Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[<i>d</i>][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Ian M. Bell, Jill M. Erb, Roger Freidinger et al. · Journal of Medicinal Chemistry · 1998 · 60 citations · Full text

Pharmacotherapy, Orally Active Oxytocin, Experimental Pharmacology +16

Synthesis and anti-herpes virus activity of acyclic 2'-deoxyguanosine analogs related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine

John C. Martin, D. P. C. MCGEE, Gary A. Jeffrey et al. · Journal of Medicinal Chemistry · 1986 · 58 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +15

Deriving Knowledge through Data Mining High-Throughput Screening Data

David Diller, Doug W. Hobbs · Journal of Medicinal Chemistry · 2004 · 46 citations

Engineering, Hit Identification, Molecular Biology +18